文献速递心境障碍

血管紧张素转换酶抑制剂经缓激肽依赖的mTORC1激活快速改善抑郁样行为

Angiotensin-Converting Enzyme Inhibitor Rapidly Ameliorates Depressive-Type Behaviors via Bradykinin-Dependent Activation of Mammalian Target of Rapamycin Complex 1.
PubMed 文献 · Biol Psychiatry · 2020-02-18

该研究在慢性不可预测应激和慢性社会挫败应激两种小鼠模型中,发现卡托普利(19.5或39 mg/kg腹腔注射)具有快速抗抑郁活性。药代动力学分析显示卡托普利可穿越血脑屏障,而血脑屏障通透性更好的赖诺普利在相同摩尔等效剂量下起效更快、更持久。该抗抑郁效应似乎不依赖肾素-血管紧张素系统,而依赖缓激肽系统,通过激活mTORC1通路快速逆转应激所致的树突棘丢失。

要点

  • 卡托普利在两种慢性应激小鼠模型中显示快速抗抑郁活性。
  • 赖诺普利因血脑屏障通透性更好,相同摩尔等效剂量下起效更快更持久。
  • 抗抑郁效应依赖缓激肽系统及下游mTORC1通路激活,不依赖肾素-血管紧张素系统。

核心结论

  • 缓激肽依赖的mTORC1激活可能是抗抑郁药理学的一个有前景的机制。
  • ACEIs可能成为新型快速起效抗抑郁药,尤其适用于抑郁与高血压共病患者。

研究设计与样本

  • 研究采用生化检测、免疫组化和行为学技术,在慢性不可预测应激模型和慢性社会挫败应激模型两种动物模型中检验卡托普利对抑郁样行为的影响及机制。

主要发现

  • 卡托普利(19.5或39 mg/kg,腹腔注射)在慢性不可预测应激模型小鼠和慢性社会挫败应激模型小鼠中均产生快速抗抑郁活性。
  • 药代动力学分析显示卡托普利可穿越血脑屏障,赖诺普利在相同摩尔等效剂量下起效更快、更持久。
  • 应激小鼠中检测到的缓激肽降低可被卡托普利逆转。
  • 缓激肽下游效应器Cdc42同源蛋白功能低下导致应激诱导的树突棘丢失,卡托普利通过激活mTORC1通路快速逆转该丢失。

关键数值与推荐

  • 卡托普利剂量为19.5或39 mg/kg,腹腔注射。
  • 赖诺普利在相同摩尔等效剂量下与卡托普利比较。

临床怎么用

  • ACEIs(如卡托普利、赖诺普利)可能作为快速起效抗抑郁药,尤其适用于抑郁与高血压共病患者。
  • 临床考虑ACEIs抗抑郁作用时需关注其血脑屏障通透性差异,赖诺普利可能因通透性更好而起效更快更持久。

局限性

  • 研究仅基于两种小鼠应激模型,尚未在人体临床试验中验证ACEIs的快速抗抑郁疗效及机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are widely prescribed antihypertensive agents. Intriguingly, case reports and clinical trials have indicated that ACEIs, including captopril and lisinopril, may have a rapid mood-elevating effect in certain patients, but few experimental studies have investigated their value as fast-onset antidepressants. METHODS: The present study consisted of a series of experiments using biochemical assays, immunohistochemistry, and behavioral techniques to examine the effect and mechanism of captopril on depressive-like behavior in 2 animal models, the chronic unpredictable stress model and the chronic social defeat stress model. RESULTS: Captopril (19.5 or 39 mg/kg, intraperitoneal injection) exerted rapid antidepressant activity in mice treated under the chronic unpredictable stress model and mice treated under the chronic social defeat stress model. Pharmacokinetic analysis revealed that captopril crossed the blood-brain barrier and that lisinopril, another ACEI with better blood-brain barrier permeability, exerted a faster and longer-lasting effect at a same molar equivalent dose. This antidepressant effect seemed to be independent of the renin-angiotensin system, but dependent on the bradykinin (BK) system, since the decreased BK detected in the stressed mice could be reversed by captopril. The hypofunction of the downstream effector of BK, Cdc42 (cell division control protein 42) homolog, contributed to the stress-induced loss of dendritic spines, which was rapidly reversed by captopril via activating the mTORC1 (mammalian target of rapamycin complex 1) pathway. CONCLUSIONS: Our findings indicate that the BK-dependent activation of mTORC1 may represent a promising mechanism underlying antidepressant pharmacology. Considering their affordability and availability, ACEIs may emerge as a novel fast-onset antidepressant, especially for patients with comorbid depression and hypertension.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Luo H, Wu PF, Cao Y, et al. Angiotensin-Converting Enzyme Inhibitor Rapidly Ameliorates Depressive-Type Behaviors via Bradykinin-Dependent Activation of Mammalian Target of Rapamycin Complex 1. Biol Psychiatry. 2020. PMID: 32220499. doi:10.1016/j.biopsych.2020.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。